DOJ to settle with maker of OxyContin for its role in opioid crisis


The company has been widely blamed for fueling the nation’s opioid epidemic.

The Justice Department is expected to announce on Wednesday a settlement of civil and criminal charges against Purdue Pharma, the OxyContin maker widely blamed for fueling the nation’s opioid epidemic.

Terms of the settlement were not immediately clear but likely involves billions of dollars in fines that Purdue will be unable to immediately pay while the company is in the middle of bankruptcy proceedings.

A spokeswoman for Purdue Pharma declined to comment but the company had signaled its intention to reach a settlement when it filed for bankruptcy protection a year ago.

The announcement is expected during an 11 a.m. news conference on Wednesday.

Purdue has also been accused of paying kickbacks to prescribers and specialty pharmacies and paying visits to doctors known to write medically unnecessary prescriptions.

This is a developing story. Please check back for updates.